APO Research
Talk to an analyst

APO RESEARCH · REPORT

IL-12 Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global IL-12 Antibody Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchIL-12 Antibody Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-12 Antibody Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal IL-12 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-12 Antibody Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-12 Antibody Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global IL-12 Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for IL-12 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for IL-12 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for IL-12 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for IL-12 Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of IL-12 Antibody include Atlas Antibodies, Bio X Cell, BioLegend, FineTest, GeneTex, Miltenyi Biotec, NSJ Bioreagents, ProSci and Proteintech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for IL-12 Antibody, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of IL-12 Antibody, also provides the revenue of main regions and countries. Of the upcoming market potential for IL-12 Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IL-12 Antibody revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IL-12 Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for IL-12 Antibody revenue, projected growth trends, production technology, application and end-user industry.

IL-12 Antibody Segment by Company

Atlas Antibodies

Bio X Cell

BioLegend

FineTest

GeneTex

Miltenyi Biotec

NSJ Bioreagents

ProSci

Proteintech

Santa Cruz Biotechnology

United States Biological

Thermo Fisher Scientific

IL-12 Antibody Segment by Type

Monoclonal

Polyclonal

IL-12 Antibody Segment by Application

Western Blot

Flow Cytometry

Immunoprecipitation

Others

IL-12 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-12 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-12 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-12 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of IL-12 Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of IL-12 Antibody company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IL-12 Antibody revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global IL-12 Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monoclonal Major Player Table 3. Polyclonal Major Player Table 4. Global IL-12 Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Western Blot Major Player Table 6. Flow Cytometry Major Player Table 7. Immunoprecipitation Major Player Table 8. Others Major Player Table 9. IL-12 Antibody Industry Trends Table 10. IL-12 Antibody Industry Drivers Table 11. IL-12 Antibody Industry Opportunities and Challenges Table 12. IL-12 Antibody Industry Restraints Table 13. Global IL-12 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global IL-12 Antibody Market Size by Region (2021-2026) & (US$ Million) Table 15. Global IL-12 Antibody Market Share by Region (2021-2026) Table 16. Global IL-12 Antibody Market Size by Region (2027-2032) & (US$ Million) Table 17. Global IL-12 Antibody Market Share by Region (2027-2032) Table 18. Global IL-12 Antibody Revenue by Players (US$ Million) & (2021-2026) Table 19. Global IL-12 Antibody Revenue Market Share by Players (2021-2026) Table 20. Global IL-12 Antibody Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global IL-12 Antibody Key Players Headquarters & Area Served Table 22. Global IL-12 Antibody Players, Product Type & Application Table 23. Global IL-12 Antibody Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global IL-12 Antibody by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global IL-12 Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global IL-12 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 28. Global IL-12 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 29. Global IL-12 Antibody Revenue Market Share by Type (2021-2026) Table 30. Global IL-12 Antibody Revenue Market Share by Type (2027-2032) Table 31. Global IL-12 Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global IL-12 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 33. Global IL-12 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 34. Global IL-12 Antibody Revenue Market Share by Application (2021-2026) Table 35. Global IL-12 Antibody Revenue Market Share by Application (2027-2032) Table 36. Atlas Antibodies Company Information Table 37. Atlas Antibodies Business Overview Table 38. Atlas Antibodies IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Atlas Antibodies IL-12 Antibody Product Portfolio Table 40. Atlas Antibodies Recent Development Table 41. Bio X Cell Company Information Table 42. Bio X Cell Business Overview Table 43. Bio X Cell IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bio X Cell IL-12 Antibody Product Portfolio Table 45. Bio X Cell Recent Development Table 46. BioLegend Company Information Table 47. BioLegend Business Overview Table 48. BioLegend IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. BioLegend IL-12 Antibody Product Portfolio Table 50. BioLegend Recent Development Table 51. FineTest Company Information Table 52. FineTest Business Overview Table 53. FineTest IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. FineTest IL-12 Antibody Product Portfolio Table 55. FineTest Recent Development Table 56. GeneTex Company Information Table 57. GeneTex Business Overview Table 58. GeneTex IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. GeneTex IL-12 Antibody Product Portfolio Table 60. GeneTex Recent Development Table 61. Miltenyi Biotec Company Information Table 62. Miltenyi Biotec Business Overview Table 63. Miltenyi Biotec IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Miltenyi Biotec IL-12 Antibody Product Portfolio Table 65. Miltenyi Biotec Recent Development Table 66. NSJ Bioreagents Company Information Table 67. NSJ Bioreagents Business Overview Table 68. NSJ Bioreagents IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. NSJ Bioreagents IL-12 Antibody Product Portfolio Table 70. NSJ Bioreagents Recent Development Table 71. ProSci Company Information Table 72. ProSci Business Overview Table 73. ProSci IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. ProSci IL-12 Antibody Product Portfolio Table 75. ProSci Recent Development Table 76. Proteintech Company Information Table 77. Proteintech Business Overview Table 78. Proteintech IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Proteintech IL-12 Antibody Product Portfolio Table 80. Proteintech Recent Development Table 81. Santa Cruz Biotechnology Company Information Table 82. Santa Cruz Biotechnology Business Overview Table 83. Santa Cruz Biotechnology IL-12 Antibody Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Santa Cruz Biotechnology IL-12 Antibody Product Portfolio Table 85. Santa Cruz Biotechnology Recent Development Table 86. United States Biological Company Information Table 87. United States Biological Business Overview Table 88. United States Biological IL-12 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. United States Biological IL-12 Antibody Product Portfolio Table 90. United States Biological Recent Development Table 91. Thermo Fisher Scientific Company Information Table 92. Thermo Fisher Scientific Business Overview Table 93. Thermo Fisher Scientific IL-12 Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Thermo Fisher Scientific IL-12 Antibody Product Portfolio Table 95. Thermo Fisher Scientific Recent Development Table 96. North America IL-12 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 97. North America IL-12 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 98. North America IL-12 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 99. North America IL-12 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 100. North America IL-12 Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America IL-12 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 102. North America IL-12 Antibody Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe IL-12 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe IL-12 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe IL-12 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe IL-12 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe IL-12 Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe IL-12 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe IL-12 Antibody Revenue by Country (US$ Million) & (2027-2032) Table 110. China IL-12 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 111. China IL-12 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 112. China IL-12 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 113. China IL-12 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia IL-12 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia IL-12 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia IL-12 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia IL-12 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia IL-12 Antibody Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia IL-12 Antibody Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia IL-12 Antibody Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA IL-12 Antibody Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA IL-12 Antibody Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA IL-12 Antibody Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA IL-12 Antibody Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA IL-12 Antibody Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA IL-12 Antibody Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA IL-12 Antibody Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. IL-12 Antibody Image Figure 2. Global IL-12 Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-12 Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monoclonal Image Figure 5. Polyclonal Image Figure 6. Global IL-12 Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global IL-12 Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 8. Western Blot Image Figure 9. Flow Cytometry Image Figure 10. Immunoprecipitation Image Figure 11. Others Image Figure 12. Global IL-12 Antibody Market Size (US$ Million) & (2021-2032) Figure 13. Global IL-12 Antibody Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global IL-12 Antibody Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global IL-12 Antibody Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global IL-12 Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global IL-12 Antibody Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global IL-12 Antibody Revenue Market Share by Type (2021-2032) Figure 20. Global IL-12 Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global IL-12 Antibody Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global IL-12 Antibody Revenue Market Share by Application (2021-2032) Figure 23. North America IL-12 Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America IL-12 Antibody Revenue Share by Type (2021-2032) Figure 25. North America IL-12 Antibody Revenue Share by Application (2021-2032) Figure 26. North America IL-12 Antibody Revenue Share by Country (2021-2032) Figure 27. United States IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe IL-12 Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe IL-12 Antibody Revenue Share by Type (2021-2032) Figure 32. Europe IL-12 Antibody Revenue Share by Application (2021-2032) Figure 33. Europe IL-12 Antibody Revenue Share by Country (2021-2032) Figure 34. Germany IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China IL-12 Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China IL-12 Antibody Revenue Share by Type (2021-2032) Figure 44. China IL-12 Antibody Revenue Share by Application (2021-2032) Figure 45. Asia IL-12 Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia IL-12 Antibody Revenue Share by Type (2021-2032) Figure 47. Asia IL-12 Antibody Revenue Share by Application (2021-2032) Figure 48. Asia IL-12 Antibody Revenue Share by Region (2021-2032) Figure 49. Japan IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA IL-12 Antibody Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA IL-12 Antibody Revenue Share by Type (2021-2032) Figure 57. SAMEA IL-12 Antibody Revenue Share by Application (2021-2032) Figure 58. SAMEA IL-12 Antibody Revenue Share by Country (2021-2032) Figure 59. Brazil IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt IL-12 Antibody Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal
  • Polyclonal
Applications
  • Western Blot
  • Flow Cytometry
  • Immunoprecipitation
  • Others
Companies covered
  • Atlas Antibodies
  • Bio X Cell
  • BioLegend
  • FineTest
  • GeneTex
  • Miltenyi Biotec
  • NSJ Bioreagents
  • ProSci
  • Proteintech
  • Santa Cruz Biotechnology
  • United States Biological
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 IL-12 Antibody Market by Type
  3. 1.2.1 Global IL-12 Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monoclonal
  5. 1.2.3 Polyclonal
  6. 1.3 IL-12 Antibody Market by Application
  7. 1.3.1 Global IL-12 Antibody Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Western Blot
  9. 1.3.3 Flow Cytometry
  10. 1.3.4 Immunoprecipitation
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 IL-12 Antibody Market Dynamics
  1. 2.1 IL-12 Antibody Industry Trends
  2. 2.2 IL-12 Antibody Industry Drivers
  3. 2.3 IL-12 Antibody Industry Opportunities and Challenges
  4. 2.4 IL-12 Antibody Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global IL-12 Antibody Market Perspective (2021-2032)
  2. 3.2 Global IL-12 Antibody Growth Trends by Region
  3. 3.2.1 Global IL-12 Antibody Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global IL-12 Antibody Market Size by Region (2021-2026)
  5. 3.2.3 Global IL-12 Antibody Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global IL-12 Antibody Revenue by Players
  2. 4.1.1 Global IL-12 Antibody Revenue by Players (2021-2026)
  3. 4.1.2 Global IL-12 Antibody Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global IL-12 Antibody Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global IL-12 Antibody Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global IL-12 Antibody Key Players Headquarters & Area Served
  7. 4.4 Global IL-12 Antibody Players, Product Type & Application
  8. 4.5 Global IL-12 Antibody Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global IL-12 Antibody Market CR5 and HHI
  11. 4.6.3 2025 IL-12 Antibody Tier 1, Tier 2, and Tier 3
5 IL-12 Antibody Market Size by Type
  1. 5.1 Global IL-12 Antibody Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global IL-12 Antibody Revenue by Type (2021-2032)
  3. 5.3 Global IL-12 Antibody Revenue Market Share by Type (2021-2032)
6 IL-12 Antibody Market Size by Application
  1. 6.1 Global IL-12 Antibody Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global IL-12 Antibody Revenue by Application (2021-2032)
  3. 6.3 Global IL-12 Antibody Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Atlas Antibodies
  2. 7.1.1 Atlas Antibodies Company Information
  3. 7.1.2 Atlas Antibodies Business Overview
  4. 7.1.3 Atlas Antibodies IL-12 Antibody Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Atlas Antibodies IL-12 Antibody Product Portfolio
  6. 7.1.5 Atlas Antibodies Recent Developments
  7. 7.2 Bio X Cell
  8. 7.2.1 Bio X Cell Company Information
  9. 7.2.2 Bio X Cell Business Overview
  10. 7.2.3 Bio X Cell IL-12 Antibody Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bio X Cell IL-12 Antibody Product Portfolio
  12. 7.2.5 Bio X Cell Recent Developments
  13. 7.3 BioLegend
  14. 7.3.1 BioLegend Company Information
  15. 7.3.2 BioLegend Business Overview
  16. 7.3.3 BioLegend IL-12 Antibody Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BioLegend IL-12 Antibody Product Portfolio
  18. 7.3.5 BioLegend Recent Developments
  19. 7.4 FineTest
  20. 7.4.1 FineTest Company Information
  21. 7.4.2 FineTest Business Overview
  22. 7.4.3 FineTest IL-12 Antibody Revenue and Gross Margin (2021-2026)
  23. 7.4.4 FineTest IL-12 Antibody Product Portfolio
  24. 7.4.5 FineTest Recent Developments
  25. 7.5 GeneTex
  26. 7.5.1 GeneTex Company Information
  27. 7.5.2 GeneTex Business Overview
  28. 7.5.3 GeneTex IL-12 Antibody Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GeneTex IL-12 Antibody Product Portfolio
  30. 7.5.5 GeneTex Recent Developments
  31. 7.6 Miltenyi Biotec
  32. 7.6.1 Miltenyi Biotec Company Information
  33. 7.6.2 Miltenyi Biotec Business Overview
  34. 7.6.3 Miltenyi Biotec IL-12 Antibody Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Miltenyi Biotec IL-12 Antibody Product Portfolio
  36. 7.6.5 Miltenyi Biotec Recent Developments
  37. 7.7 NSJ Bioreagents
  38. 7.7.1 NSJ Bioreagents Company Information
  39. 7.7.2 NSJ Bioreagents Business Overview
  40. 7.7.3 NSJ Bioreagents IL-12 Antibody Revenue and Gross Margin (2021-2026)
  41. 7.7.4 NSJ Bioreagents IL-12 Antibody Product Portfolio
  42. 7.7.5 NSJ Bioreagents Recent Developments
  43. 7.8 ProSci
  44. 7.8.1 ProSci Company Information
  45. 7.8.2 ProSci Business Overview
  46. 7.8.3 ProSci IL-12 Antibody Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ProSci IL-12 Antibody Product Portfolio
  48. 7.8.5 ProSci Recent Developments
  49. 7.9 Proteintech
  50. 7.9.1 Proteintech Company Information
  51. 7.9.2 Proteintech Business Overview
  52. 7.9.3 Proteintech IL-12 Antibody Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Proteintech IL-12 Antibody Product Portfolio
  54. 7.9.5 Proteintech Recent Developments
  55. 7.10 Santa Cruz Biotechnology
  56. 7.10.1 Santa Cruz Biotechnology Company Information
  57. 7.10.2 Santa Cruz Biotechnology Business Overview
  58. 7.10.3 Santa Cruz Biotechnology IL-12 Antibody Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Santa Cruz Biotechnology IL-12 Antibody Product Portfolio
  60. 7.10.5 Santa Cruz Biotechnology Recent Developments
  61. 7.11 United States Biological
  62. 7.11.1 United States Biological Company Information
  63. 7.11.2 United States Biological Business Overview
  64. 7.11.3 United States Biological IL-12 Antibody Revenue and Gross Margin (2021-2026)
  65. 7.11.4 United States Biological IL-12 Antibody Product Portfolio
  66. 7.11.5 United States Biological Recent Developments
  67. 7.12 Thermo Fisher Scientific
  68. 7.12.1 Thermo Fisher Scientific Company Information
  69. 7.12.2 Thermo Fisher Scientific Business Overview
  70. 7.12.3 Thermo Fisher Scientific IL-12 Antibody Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Scientific IL-12 Antibody Product Portfolio
  72. 7.12.5 Thermo Fisher Scientific Recent Developments
8 North America
  1. 8.1 North America IL-12 Antibody Revenue (2021-2032)
  2. 8.2 North America IL-12 Antibody Revenue by Type (2021-2032)
  3. 8.2.1 North America IL-12 Antibody Revenue by Type (2021-2026)
  4. 8.2.2 North America IL-12 Antibody Revenue by Type (2027-2032)
  5. 8.3 North America IL-12 Antibody Revenue Share by Type (2021-2032)
  6. 8.4 North America IL-12 Antibody Revenue by Application (2021-2032)
  7. 8.4.1 North America IL-12 Antibody Revenue by Application (2021-2026)
  8. 8.4.2 North America IL-12 Antibody Revenue by Application (2027-2032)
  9. 8.5 North America IL-12 Antibody Revenue Share by Application (2021-2032)
  10. 8.6 North America IL-12 Antibody Revenue by Country
  11. 8.6.1 North America IL-12 Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America IL-12 Antibody Revenue by Country (2021-2026)
  13. 8.6.3 North America IL-12 Antibody Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe IL-12 Antibody Revenue (2021-2032)
  2. 9.2 Europe IL-12 Antibody Revenue by Type (2021-2032)
  3. 9.2.1 Europe IL-12 Antibody Revenue by Type (2021-2026)
  4. 9.2.2 Europe IL-12 Antibody Revenue by Type (2027-2032)
  5. 9.3 Europe IL-12 Antibody Revenue Share by Type (2021-2032)
  6. 9.4 Europe IL-12 Antibody Revenue by Application (2021-2032)
  7. 9.4.1 Europe IL-12 Antibody Revenue by Application (2021-2026)
  8. 9.4.2 Europe IL-12 Antibody Revenue by Application (2027-2032)
  9. 9.5 Europe IL-12 Antibody Revenue Share by Application (2021-2032)
  10. 9.6 Europe IL-12 Antibody Revenue by Country
  11. 9.6.1 Europe IL-12 Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe IL-12 Antibody Revenue by Country (2021-2026)
  13. 9.6.3 Europe IL-12 Antibody Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China IL-12 Antibody Revenue (2021-2032)
  2. 10.2 China IL-12 Antibody Revenue by Type (2021-2032)
  3. 10.2.1 China IL-12 Antibody Revenue by Type (2021-2026)
  4. 10.2.2 China IL-12 Antibody Revenue by Type (2027-2032)
  5. 10.3 China IL-12 Antibody Revenue Share by Type (2021-2032)
  6. 10.4 China IL-12 Antibody Revenue by Application (2021-2032)
  7. 10.4.1 China IL-12 Antibody Revenue by Application (2021-2026)
  8. 10.4.2 China IL-12 Antibody Revenue by Application (2027-2032)
  9. 10.5 China IL-12 Antibody Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia IL-12 Antibody Revenue (2021-2032)
  2. 11.2 Asia IL-12 Antibody Revenue by Type (2021-2032)
  3. 11.2.1 Asia IL-12 Antibody Revenue by Type (2021-2026)
  4. 11.2.2 Asia IL-12 Antibody Revenue by Type (2027-2032)
  5. 11.3 Asia IL-12 Antibody Revenue Share by Type (2021-2032)
  6. 11.4 Asia IL-12 Antibody Revenue by Application (2021-2032)
  7. 11.4.1 Asia IL-12 Antibody Revenue by Application (2021-2026)
  8. 11.4.2 Asia IL-12 Antibody Revenue by Application (2027-2032)
  9. 11.5 Asia IL-12 Antibody Revenue Share by Application (2021-2032)
  10. 11.6 Asia IL-12 Antibody Revenue by Country
  11. 11.6.1 Asia IL-12 Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia IL-12 Antibody Revenue by Country (2021-2026)
  13. 11.6.3 Asia IL-12 Antibody Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA IL-12 Antibody Revenue (2021-2032)
  2. 12.2 SAMEA IL-12 Antibody Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA IL-12 Antibody Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA IL-12 Antibody Revenue by Type (2027-2032)
  5. 12.3 SAMEA IL-12 Antibody Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA IL-12 Antibody Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA IL-12 Antibody Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA IL-12 Antibody Revenue by Application (2027-2032)
  9. 12.5 SAMEA IL-12 Antibody Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA IL-12 Antibody Revenue by Country
  11. 12.6.1 SAMEA IL-12 Antibody Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA IL-12 Antibody Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA IL-12 Antibody Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst